In conclusion, our study revealed that the treatment of GBM cells with UCMSC-CM significantly increased the expression of survivin, TRAIL protein and DcR1, but it only slightly increased the expression of caspase-9 and DR4. The gene discussed is TNFRSF10C; the disease is glioblastoma.